Overall, the range of effectiveness across all 36 modalities was reduced in the newer review. The reanalysis did not show a relationship between effectiveness and cost. When only those 26 modalities that had been documented by three or more studies were included, greater cost was related to lower effectiveness, but this relationship was not statistically significant.
